Liposomes-loaded miR-128-3p exert neuroprotective effects in hypoxia-ischemia injury by targeting Rgs1 in neonatal mice
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178153 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Luyao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China. Hauptthemen laut MEDLINE: MicroRNAs, Hypoxia-Ischemia, Brain, Neuroprotective Agents, RGS Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Shandong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Perinatal brain injury due to severe hypoxia-ischemia (HI) is a significant cause of neonatal mortality and high prevalence of long-term chronic disease on a global scale, whose clinical treatment is still limited to therapeutic hypothermia with limited efficacy. MiRNA-128 is a brain-enriched microcoding RNA that is highly expressed in the central nervous system. In this study, we found that miR-128-3p expression, a predicted down-regulated microRNA (miRNA) in GSE213067, was significantly reduced in ipsilateral cortical tissues after HI injury in pups. Then we successfully constructed a well-dispersed and uniformly sized liposome-encapsulated miR-128-3p nanoparticle (miR-128-3p@Lipo), with exhibited good stability and biosafety. Moreover, the use of a miR-128-3p@Lipo nanoparticle delivery system could simultaneously deliver miR-128-3p to neuron via a non-invasive intranasal route. Up-regulation of miR-128-3p levels in the ipsilateral cortical tissues via miR-128-3p@Lipo significantly ameliorated cerebral infarcts, apoptosis, neuroinflammation, and reactive oxygen species levels and facilitated the recovery of neurological function after HI injury in neonatal mice. Further mechanistic exploration revealed that miR-128-3p may exert neuroprotective effects by inhibiting the expression of the downstream target gene Regulating G protein signaling 1 (Rgs1). This work suggests that miRNAs offer a therapeutic potential to mitigate HI brain damage in neonatal mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
- Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.
- Department of Medical Psychology and Ethics, School of Basic Medicine Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China. Electronic address: liudexiang@sdu.edu.cn.
- Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China. Electronic address: wangzhen@sdu.edu.cn.
Förderung
- Natural Science Foundation of Shandong Province
- Shandong University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, L., Cheng, Y., Zhao, Y., Chen, W., Liu, D., & Wang, Z. (2025). Liposomes-loaded miR-128-3p exert neuroprotective effects in hypoxia-ischemia injury by targeting Rgs1 in neonatal mice. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178153
Vancouver
Zhang L, Cheng Y, Zhao Y, Chen W, Liu D, Wang Z. Liposomes-loaded miR-128-3p exert neuroprotective effects in hypoxia-ischemia injury by targeting Rgs1 in neonatal mice. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178153
BibTeX
@article{Zhang2025,
author = {Zhang, Luyao and Cheng, Yahong and Zhao, Yijing and Chen, Wenqiang and Liu, Dexiang and Wang, Zhen},
title = {Liposomes-loaded miR-128-3p exert neuroprotective effects in hypoxia-ischemia injury by targeting Rgs1 in neonatal mice},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178153}
}
EUVIMED